Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.
about
HIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous system.Neurological immune reconstitution inflammatory response: riding the tide of immune recoveryMorphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neuritesPlatelet Activation in Human Immunodeficiency Virus Type-1 Patients Is Not Altered with Cocaine AbuseHIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens.The use of Nanotrap particles technology in capturing HIV-1 virions and viral proteins from infected cells.Three-dimensional imaging of HIV-1 virological synapses reveals membrane architectures involved in virus transmission.HIV-1 Tat-induced changes in synaptically-driven network activity adapt during prolonged exposure.STAT3 and its phosphorylation are involved in HIV-1 Tat-induced transactivation of glial fibrillary acidic proteinHIV-1-Tat excites cardiac parasympathetic neurons of nucleus ambiguus and triggers prolonged bradycardia in conscious rats.Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression.HIV-1 Tat inhibits EAAT-2 through AEG-1 upregulation in models of HIV-associated neurocognitive disorder.RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.Challenges in HIV Vaccine Research for Treatment and Prevention.Interaction between HIV-1 Tat and DNA-PKcs modulates HIV transcription and class switch recombination.Effects of HIV-1 Tat on enteric neuropathogenesis.New insights into immune reconstitution inflammatory syndrome of the central nervous system.Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphineEffects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behaviorHIV-1 Tat C phosphorylates VE-cadherin complex and increases human brain microvascular endothelial cell permeability.Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.Sensitization of enteric neurons to morphine by HIV-1 Tat protein.HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trialEradication of human immunodeficiency virus from brain reservoirs.HIV eradication symposium: will the brain be left behind?Oligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development.HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.Chronic HIV-1 Tat and HIV reduce Rbfox3/NeuN: evidence for sex-related effectsHIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trialHIV-1 Tat Regulates Occludin and Aβ Transfer Receptor Expression in Brain Endothelial Cells via Rho/ROCK Signaling PathwayUpdate on HIV-associated neurocognitive disorders.HIV-1 Tat-shortened neurite outgrowth through regulation of microRNA-132 and its target gene expression.HIV-1 Tat Inhibits Autotaxin Lysophospholipase D Activity and Modulates Oligodendrocyte DifferentiationCentral nervous system immune reconstitution inflammatory syndrome.HIV Tat Impairs Neurogenesis through Functioning As a Notch Ligand and Activation of Notch Signaling Pathway.NMDARs Adapt to Neurotoxic HIV Protein Tat Downstream of a GluN2A-Ubiquitin Ligase Signaling Pathway.Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.Synaptodendritic injury with HIV-Tat protein: What is the therapeutic target?
P2860
Q27318687-C5EFBFDA-0CC4-4500-AA28-A73C94032B8BQ28082309-F15FBDEA-72FD-40A6-B6FF-C553ED72AED6Q28539889-4B1755CC-5986-4874-832D-52060CC73188Q28548326-40B3FF4E-5673-41B5-AC25-8FB1450BBC52Q30397434-FF0909B9-486A-459A-849F-A9189ABAA0E7Q30413065-F16FB5DE-F497-4C27-B055-DA60C235DA58Q30588474-C9AADC04-DAA1-4E84-BB01-F22CDAC4A0D3Q30638542-BABE5D9B-F9AD-4B0A-AC0D-553B984B88BFQ33675464-11F3667E-CCB2-4013-906E-7CFDE1DA7A2DQ33701989-0F9B5139-9DE3-4107-A61A-A94E2106CAF9Q33888584-DF761AD8-954A-4A70-9E5D-B3EFC0DCF62EQ33889434-6C3876EF-F9E8-43CA-BD54-AB378EA6ECCCQ34025414-BDC2A3C7-0D5D-4352-ACA9-D159BC76481EQ34148683-50517AE4-CA16-46B3-B0A7-7AC8FD07F6A7Q34365204-28785B1F-3CDC-4A11-AA24-E6FC4D0D2DB4Q34383417-9EE35C35-7B4A-4C87-8AB0-567C27B07343Q34433828-07A290D1-D10B-4AAE-8216-43CF62476249Q34540333-0C71AADE-DAF9-4550-BC1E-2A16E5530F02Q34988973-AC1CD96A-650E-4B11-AE40-0FFF1C3295A9Q35123216-89FC5880-4690-44A7-AD85-331ECBFD4343Q35194936-4AF1A28E-283A-47D5-9A8E-4F2DE6185CB3Q35215063-CAE0740D-01CF-457D-9785-44B8A6F93B14Q35236345-8BC4B08C-C291-4D1C-97F5-3096FE748CDEQ35552889-A87A8FD8-663E-4B7B-9214-B96DBDFA69AAQ35567289-6826532C-950D-4F24-9AB2-219F7DE8E1FFQ35607587-C210B093-497D-4522-A4C4-D39EF19FF3DCQ35941437-84BDF9E0-A82A-4BCC-BE92-14BAA3ED8E2EQ36109585-48D1C72B-8415-4D14-8CB9-D72B285337E0Q36335361-54A3F8E6-CF83-40EF-9023-04AE21824D5DQ36407266-D07DB25C-8AF4-4351-BE6D-BD62CD288CCBQ36986644-7C4C33C2-DFF5-4B3C-94AE-C5E021CAE911Q37176830-91FCD74C-8988-4F36-8C15-49A5E183834BQ37200962-E2AB2166-4D28-41C3-AFB5-40A2FD6AD9BEQ37260505-B7DEAF96-17EE-418E-81B4-755BDC5635EAQ37282230-8380EEE8-AD2B-4ED2-8609-DDB5798155F0Q37442512-4BAE6A85-BB1A-4535-AD29-A45AAFFE2209Q37490454-67EE54A0-67D9-4F7D-ABC1-2717F77BE86AQ37504979-95F81225-8E3C-4342-8607-67A5D960E234Q37547409-A4A7B6CC-9275-4A68-BB7B-58B3FF01505CQ37597459-A4DCACCF-15C3-4415-866C-D3A52650D329
P2860
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.
@en
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.
@nl
type
label
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.
@en
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.
@nl
prefLabel
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.
@en
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.
@nl
P2093
P2860
P356
P1476
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.
@en
P2093
Avindra Nath
Dragan Maric
Karan Patel
Kory R Johnson
Rodrigo Hasbun
Tory P Johnson
P2860
P304
13588-13593
P356
10.1073/PNAS.1308673110
P407
P577
2013-07-29T00:00:00Z